Ranked by Value Score · updated September 2026
The best tirzepatide programs — not just the cheapest.
368 programs publish a real tirzepatide price. Ranked here by our six-factor Value Score — price, coverage, cancellation terms and whether the rate holds — not sorted by sticker alone. Want the lowest number instead? See the cheapest tirzepatide price ladder.
Best tirzepatide, ranked
Value-Score sorted, not price-sorted
54 of 368 carry our flat-price flag — the month-one rate is the month-twelve rate. Assume any program we list may compensate us; it never moves this order. See our disclosure.
- $149/moHolds flat
- $149/moHolds flat
- From $125/moWatch terms$125/mo on the annual plan
- From $224/moHolds flat$224.99/mo at every dose (as low as $144.49 on a longer plan)FDA warning letter, February 2026 — FDA database
- From $299/moWatch termsBrand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg) — plus Sesame care: $59/mo on the 12-month prepay, otherwise $99 per 28 days
- From $159/moHolds flatFrom $159/mo (same price at every dose)
- From $268/moWatch terms$268/mo on the annual plan
- From $140/moWatch termsFrom $140/mo
- From $239/moWatch terms$239/mo month-to-month ($149 first month, renews at $214) · $209/mo on a 3-month plan · $179/mo on a 12-month prepay ($2,148)
- $219/moWatch terms
- From $329/moWatch terms$329/mo month-to-month (as low as $243/mo)
- From $199/moHolds flatFrom $199/mo (all doses, 3-month plan, compounded)FDA warning letter, February 2026 — FDA database
- From $129/moWatch termsFrom $129/mo (all doses, promotional rate, compounded)
- From $329Watch terms$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay
- From $133/moWatch termsFrom $133/mo (starting dose, promotional rate, compounded)
- From $399/moHolds flat$399/mo quarterly (from $369/mo on 6 months)
- From $249/moHolds flat$249/mo month-to-month (a separate low-dose program is $140)
- From $139/moWatch terms$139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)
That is the top 20 of 368 priced tirzepatide programs. Every one of the other 348 still has its own review and ranks somewhere on the full index.
Best and cheapest aren't the same question
CoreAge Rx tops this site at 93/100, publishing tirzepatide at $149/mo. The lowest sticker among the same 368 programs belongs to Collective at $69/mo month-to-month plus a separate fee — a required $199-a-year membership — The medication really is $59 and $69 a month, and those are standing rates rather than introductory ones — but nobody pays only that. A $199 annual membership is required, and the headline that carries the site, "Get GLP-1s at $59/month", leaves it out; it appears in a card panel, a small disclaimer and the questions. Twelve months of semaglutide is therefore $708 in medication plus $199 in membership, or $907, which is about $76 a month; tirzepatide works out to $1,027, about $86. The site's own comparison chart quietly uses the tirzepatide basket. The membership runs on a twenty-one-day free trial that converts automatically, renews annually, and is not refundable in part. And the terms reserve a "nominal, uniform technology transaction fee" for each electronic prescription that is never given an amount, on a site that promises no hidden costs.
Neither number is wrong; they answer different questions. If price is the only thing you're optimizing, start with the cheapest tirzepatide ladder and read the teaser flag on whatever comes up first — a low month-one number that steps up in month two isn't actually the cheapest thing you'll pay. If you want the program most likely to be a good deal on the whole, this site is built for that instead.
Brand-name Zepbound and Mounjaro are Eli Lilly's FDA-approved tirzepatide; most programs above sell compounded tirzepatide, a different, non-FDA-approved product. Vet the pharmacy before you shop on either axis — start with is cheap compounded GLP-1 safe?.
Which ranking is for you
- Cheapest tirzepatide, ranked by price — the same eligible set, sorted strictly ascending by sticker price.
- Best tirzepatide, ranked by Value Score — this page: quality-first, price is one factor of six.
- Best semaglutide, ranked by Value Score — the same approach for the lower-ceiling molecule.
- Cheapest GLP-1 programs, ranked — every program regardless of molecule, cheapest sticker first.
Best tirzepatide, answered
- What is the best tirzepatide program?
- Of the 368 programs that publish a real tirzepatide price, CoreAge Rx ranks highest on our Value Score at 93/100 — The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one. That is a different answer than "cheapest": the lowest sticker among the same set is Collective at $69/mo month-to-month plus a separate fee — a required $199-a-year membership.
- What does "best" mean here if it isn't the cheapest price?
- Our Value Score weighs price alongside five other factors — coverage, cancellation terms, whether the rate holds after month one, and more. A program can publish a low first-month number and still score lower here if that number doesn't hold, or if it comes with restrictions a cheaper-looking ranking wouldn't show you.
- Is this the same list as the cheapest tirzepatide ranking?
- Overlapping but reordered. Both draw from the same 368 programs with a disclosed tirzepatide price. The cheapest ranking sorts strictly ascending by that price; this one sorts by Value Score, so a program with a higher sticker but a flat rate and full state coverage can rank above a cheaper one flagged "watch."
- Is compounded tirzepatide the same as Zepbound or Mounjaro?
- No. Zepbound and Mounjaro are Eli Lilly's FDA-approved brand-name tirzepatide. Most programs ranked below sell compounded tirzepatide instead — a different product that is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality the same way.
Next: semaglutide vs tirzepatide: the cheaper effective GLP-1, or compare any two programs head-to-head.
Not medical advice; see our medical disclaimer and methodology.